What is the Curiox Biosystems Co., Ltd. stock price forecast?

Curiox Biosystems Co., Ltd. is currently trading at ₩64,800. View real-time AI analysis on Alpha Lenz.

What is Curiox Biosystems Co., Ltd. insider trading activity?

View the latest insider trading data for Curiox Biosystems Co., Ltd. on Alpha Lenz.

What is Curiox Biosystems Co., Ltd.'s P/E ratio?

Curiox Biosystems Co., Ltd.'s P/E ratio is -43.6.

Curiox Biosystems Co., Ltd.

KRX · 445680

₩64,800-4,100(-5.95%)Market closed

Ask about Curiox Biosystems Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Curiox Biosystems Co., Ltd. trades at a P/E of -43.6 (undervalued) with modest ROE of -53.6%.”

Ask for details →

Company Overview

Curiox Biosystems Co., Ltd. is a pioneering biotechnology company specializing in innovative solutions for cellular analysis and research. The company's primary focus is on enhancing the efficiency and accuracy of laboratory procedures, notably through its patented DropArray technology. This unique platform reduces the need for centrifugation in sample preparation, offering a gentle and efficient way to handle cells across various research applications, including immuno-oncology and vaccine development. Curiox Biosystems' solutions cater to the pharmaceutical, biotechnology, and academic research industries, providing tools that streamline workflows and improve data reliability. By addressing critical challenges in cell analysis, Curiox plays a significant role in advancing scientific research and development. Headquartered in South Korea, the company has a growing global presence, supporting laboratories worldwide with its cutting-edge products and contributing to the acceleration of various therapeutic discoveries.

CEO김남용

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩1,185,304,269,500Market Cap

₩5,151,548,430Revenue

17.20MShares Out

0Employees

Margins

41.45%Gross

-189.40%EBITDA

-238.68%Operating

-530.56%Pre-Tax

-527.56%Net

Valuation

-43.61P/E

22.45P/B

230.09EV/Sales

-120.22EV/EBITDA

-105.40P/FCF

Growth (CAGR)

-10.71%Rev 3Yr

3.28%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-36.58%ROA

-53.58%ROE

-35.19%ROIC

Financial Health

₩14,785,429,130Cash & Cash Equivalents

₩10,432,504,390Net Debt

47.75%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Curiox Biosystems Co., Ltd. trades at a P/E of -43.6 (undervalued) with modest ROE of -53.6%.”

Ask for details →

Frequently Asked Questions

Curiox Biosystems Co., Ltd. (ticker: 445680) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $1.2T.

The current price is ₩64,800 with a P/E ratio of -43.61x and P/B of 22.45x.

ROE is -53.58% and operating margin is -238.68%. Annual revenue is $5.2B.